AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Elmos Semiconductor SE

Earnings Release Nov 5, 2020

137_10-q_2020-11-05_dc02e2f9-67ad-4f9b-a128-fc6c9d9832b9.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Quarterly statement Q3 2020

July 1 to September 30, 2020

Signifi cant recovery in current Q4 2020 – full-year guidance 2020 above market expectations Q3 2020 at the upper end of guidance range: Sales at 40.9 million Euro / EBIT at -10.5 million Euro

"As expected, the third quarter of 2020 was clearly a turning point. We are seeing significant recovery in our business with very strong sequential growth in the fourth quarter of 2020. Due to this noticeable improvement, the full-year guidance for 2020 is above market expectations. This recovery is widespread, however the strongest impetus is coming from Asia," says Dr. Anton Mindl, CEO of Elmos Semiconductor SE. "In spite of the current rise in coronavirus infections, our intensive work on numerous new projects and our known strong product portfolio puts us in a confident mood when it comes to our medium- to long-term development."

Key figures

in million Euro unless otherwise indicated Q3 2020 Q3 20191 Change 9M 2020 9M 20191 Change
Sales 40.9 67.8 -39.7% 163.9 197.7 -17.1%
Gross profit 11.9 32.5 -63.4% 64.6 91.1 -29.0%
in % of sales 29.1% 47.9% 39.4% 46.1%
Research and development expenses 11.1 10.6 4.0% 36.0 29.6 21.6%
in % of sales 27.1% 15.7% 21.9% 15.0%
Operating income -7.0 9.1 n/a 1.2 28.5 -95.9%
in % of sales -17.2% 13.4% 0.7% 14.4%
EBIT -10.5 9.7 n/a -0.2 29.8 n/a
in % of sales -25.7% 14.3% -0.2% 15.1%
Consolidated net loss (-)/
consolidated net income after
non-controlling interests -6.2 4.3 n/a 0.6 17.4 -96.3%
in % of sales -15.1% 6.4% 0.4% 8.8%
Earnings per share (basic) in Euro -0.34 0.22 n/a 0.03 0.89 -96.1%
09/30/2020 06/30/2020 Change 09/30/2020 12/31/2019 Change
Total assets 394.9 405.5 -2.6% 394.9 439.5 -10.2%
Shareholders' equity 304.5 310.3 -1.9% 304.5 339.7 -10.4%
in % of total assets 77.1% 76.5% 77.1% 77.3%
Financial liabilities 46.2 47.5 -2.7% 46.2 49.1 -5.8%
Liquid assets and securities 85.6 87.1 -1.6% 85.6 123.3 -30.6%
Net cash 39.4 39.5 -0.3% 39.4 74.3 -47.0%
Q3 2020 Q3 2019 Change 9M 2020 9M 2019 Change
Cash flow from operating activities 3.2 15.0 -78.7% 17.5 32.6 -46.2%
Capital expenditures 3.7 7.4 -49.9% 12.9 32.7 -60.6%
in % of sales 9.1% 9.9%2 7.9% 14.9%3
Adjusted free cash flow -0.5 88.3 n/a 2.6 76.2 -96.6%

Prior-year amounts were adjusted; for purposes of comparison, information regarding the consolidated income statement relates exclusively to continuing operations.

2 Percentage shown relates to sales from continuing and discontinued operations of 75,025 thousand Euro.

Percentage shown relates to sales from continuing and discontinued operations of 219,146 thousand Euro.

Definitions of selected financial indicators

  • Adjusted free cash flow: Cash flow from operating activities less capital expenditures for/plus disposal of intangible assets and property, plant and equipment (including payments from the disposal of consolidated companies)

  • Capital expenditures: Capital expenditures in intangible assets and property, plant and equipment less capitalized development costs - Further information on the key figures used can be found in the 2019 Annual Report at www.elmos.com

Profit, financial position, as well as assets and liabilities

  • -> The sales and earnings performance in the third quarter of 2020 is at the upper end of the given guidance range.
  • -> Capital expenditures remain at a low level in response to the coronavirus pandemic.
  • -> Adjusted free cash flow was almost balanced in the reporting quarter.
  • -> All production departments and significant parts of the administration were operating on short-time work in the third quarter of 2020 due to the coronavirus pandemic.
  • -> The ratio of orders received for the next three months to sales over the past three months, known as the book-to-bill ratio, was well above one at the end of the reporting period.
  • -> We are seeing significant recovery in our business with very strong sequential growth in the fourth quarter of 2020.

The figures relate exclusively to continuing operations.

Guidance

Guidance for the Fiscal Year 2020 (as of November 3, 2020)
Sales 227 to 233 million Euro
EBIT 6 to 9 million Euro
ø Exchange rate 1.15 EUR/USD

Condensed consolidated statement of financial position

Assets in thousand Euro 09/30/2020 12/31/2019
Intangible assets 30,845 32,864
Property, plant and equipment 132,018 137,803
Securities 43,441 17,324
Investments 1 1
Other financial assets 6,255 4,704
Deferred tax assets 128 56
Non-current assets 212,688 192,751
Inventories 94,346 78,759
Trade receivables 27,956 50,928
Securities 4,722 11,003
Other financial assets 1,056 3,418
Other receivables 6,562 7,242
Income tax assets 10,081 403
Cash and cash equivalents 37,478 95,018
Current assets 182,201 246,771
Total assets 394,889 439,522
Equity and liabilities in thousand Euro 09/30/2020 12/31/2019
Share capital 20,104 20,104
Treasury shares -1,986 -469
Additional paid-in capital 57,692 82,490
Surplus reserve 102 102
Other equity components 13 123
Retained earnings 227,968 236,732
Equity attributable to owners of the parent 303,893 339,081
Non-controlling interests 607 582
Equity 304,499 339,663
Financial liabilities 43,131 44,680
Deferred tax liabilities 4,840 7,284
Non-current liabilities 47,971 51,964
Provisions 20,403 22,233
Income tax liabilities 213 6,157
Financial liabilities 3,116 4,390
Trade payables 12,025 10,159
Other liabilities 6,662 4,956
Current liabilities 42,419 47,895
Liabilities 90,389 99,859
Total equity and liabilities 394,889 439,522
in thousand Euro Q3 2020 Q3 20191 9M 2020 9M 20191
Sales 40,882 75,025 163,893 219,146
thereof from discontinued operations 0 7,206 0 21,448
Sales from continuing operations 40,882 67,819 163,893 197,698
CONTINUING OPERATIONS
Sales from continuing operations 40,882 67,819 163,893 197,698
Cost of sales -28,978 -35,324 -99,244 -106,611
Gross profit 11,904 32,494 64,649 91,087
Research and development expenses -11,059 -10,629 -35,953 -29,573
Distribution expenses -4,071 -4,775 -14,479 -14,761
Administrative expenses -3,794 -8,037 -13,061 -18,218
Operating result before other operating expenses (-)/income -7,020 9,054 1,157 28,535
Foreign exchange losses (-)/gains -1,091 1,083 -808 968
Other operating income 412 803 2,649 2,137
Other operating expenses -2,794 -1,230 -3,244 -1,808
Earnings before interest and taxes (EBIT) from continuing operations -10,493 9,711 -247 29,832
Finance income 119 29 375 275
Finance costs -184 -253 -679 -1,274
Earnings before taxes -10,559 9,487 -551 28,833
Income tax 4,416 -5,103 1,222 -11,322
thereof current income tax 1,405 -4,606 -1,299 -9,763
thereof deferred tax 3,011 -497 2,521 -1,559
Consolidated net loss (-)/ consolidated net income after taxes
from continuing operations -6,143 4,384 671 17,511
DISCONTINUED OPERATIONS
Consolidated net loss (-)/ consolidated net income after taxes from
discontinued operations 0 63,043 0 66,022
Consolidated net loss (-)/ consolidated net income after taxes from
continuing and discontinued operations -6,143 67,427 671 83,534
thereof attributable to owners of the parent -6,164 67,381 646 83,464
thereof attributable to non-controlling interests 21 46 25 69
Earnings per share Euro Euro Euro Euro
Basic earnings per share -0.34 0.222 0.03 0.892
Fully diluted earnings per share -0.34 0.222 0.03 0.892

Adjustment of prior-year figures according to IFRS 5 (differentiation between continuing and discontinued operations) 2 Key figure relates exclusively to continuing operations

Condensed consolidated income statement Condensed consolidated statement of cash flow

in thousand Euro Q3 2020 Q3 2019 9M 2020 9M 2019
Consolidated net loss (-)/ consolidated net income from continuing and
discontinued operations -6,143 67,427 671 83,534
Depreciation and amortization 7,353 8,148 23,138 24,041
Gains from the disposal of assets -193 -283 -163 -205
Earnings from the sale of discontinued operations 0 -61,911 0 -61,911
Financial result 66 305 304 1,242
Other non-cash income -3,011 -1,734 -2,520 -1,714
Current income tax -1,405 4,672 1,299 9,928
Expenses for stock awards/share matching 63 17 213 66
Changes in net working capital:
Trade receivables 10,857 2,657 22,973 -350
Inventories -3,222 -3,325 -15,587 -14,062
Other assets 3,578 -1,445 2,950 1,422
Trade payables -2,148 233 1,704 -2,354
Other provisions and other liabilities 1,477 1,477 -133 3,511
Income tax payments -4,148 -1,067 -16,921 -9,925
Interest paid -53 -244 -799 -902
Interest received 118 29 375 232
Cash flow from operating activities 3,189 14,956 17,504 32,552
Cash flow from investing activities
Capital expenditures for intangible assets -1,238 -1,626 -3,527 -6,698
Capital expenditures for property, plant and equipment -3,511 -7,352 -12,478 -32,064
Disposal of non-current assets 1,027 -4 1,072 35
Disposal of investments 0 19 0 19
Payments from the disposal of consolidated companies 0 82,345 0 82,345
Disposal of/payments for (-) securities 0 2,000 -19,819 15,574
Payments for other non-current financial assets -487 -120 -1,460 -362
Cash flow from investing activities -4,209 75,262 -36,212 58,849
Cash flow from financing activities
Change in current liabilities to banks 0 -89 0 -327
Share-based payment/issue of treasury shares 0 -1,369 421 -1,388
Buyback of treasury shares 0 -413 -26,949 -2,582
Repayment of lease liabilities -748 -271 -2,398 -2,534
Repayment of liabilities from installment purchase -156 -156 -465 -464
Dividend distribution 0 0 -9,409 -10,218
Other changes 25 233 86 231
Cash flow from financing activities -879 -2,065 -38,714 -17,282
Decrease (-)/increase in cash and cash equivalents -1,899 88,152 -57,422 74,119
Effects of exchange rate changes on cash and cash equivalents -82 3,122 -118 3,483
Cash and cash equivalents at beginning of reporting period 39,458 13,465 95,018 27,137
Cash and cash equivalents at end of reporting period 37,478 104,740 37,478 104,740

Financial calendar

Fiscal year 2021
Preliminary results 20201 February 17, 2021
Final results 20201 March 17, 2021
Quarterly results Q1 /20211 May 6, 2021
Annual General Meeting May 20, 2021
Quarterly results Q2/20211 August 4, 2021
Quarterly results Q3/20211 November 4, 2021

1 The German Securities Trading Act (Wertpapierhandelsgesetz) and the Market Abuse Regulation oblige issuers to announce any information that may have a substantial price impact immediately, irrespective of the financial calendar. Therefore, we cannot rule out having to announce key figures of quarterly and annual results ahead of the dates mentioned above. As we can never rule out changes of dates, we recommend checking them in advance on the website (www.elmos.com).

Contact

Janina Rosenbaum | Investor Relations

Phone: + 49 (0) 231-75 49-287 Fax: + 49 (0) 231-75 49-111 [email protected]

Elmos Semiconductor SE

Heinrich-Hertz-Straße 1 44227 Dortmund | Germany Phone: + 49 (0) 231-75 49-0 Fax: + 49 (0) 231-75 49-149 [email protected] | www.elmos.com

Note

This document is a quarterly statement pursuant to section 51a of the rules and regulations for the Frankfurter Wertpapierbörse. Due to calculation processes, tables and references may produce rounding differences from the mathematically exact values (monetary units, percentage statements, etc.).

Forward-looking statements

This report contains statements directed to the future that are based on assumptions and estimates made by the management of Elmos. Even though we assume the underlying expectations of our forward-looking statements to be realistic, we cannot guarantee these expectations will prove right. The assumptions may carry risks and uncertainties, and as a result actual events may differ materially from the current statements made with respect to the future. Among the factors that could cause material differences are changes in general economic and business conditions, changes in exchange and interest rates, the introduction of competing products, lack of acceptance of new products, and changes in business strategy. Elmos neither intends nor assumes any obligation to update its statements with respect to future events.

This English translation is provided for convenience only. The German text shall be the sole legally binding version.

Talk to a Data Expert

Have a question? We'll get back to you promptly.